A few months after the American Chemical Society won its lawsuit against the pirate site, the game of virtual whack-a-mole continues.
The Scientist is bringing together a panel of experts to discuss their research and share insights into targeting these pathways with anti-cancer therapeutics.
June 1, 2017|
Thursday, June 1, 2017
2:30 - 4:00 P.M. EDT
Communication between cancer cells has long been a target of drug-discovery efforts, but the conversations between cells can be convoluted and confused by signaling-pathway crosstalk, feedback loops, and other complex interactions. Recent advances have led to the elucidation of unexpected interactions between cells during the oncogenic transition, and these interactions are specific to the tumor microenvironment. To explore the advances in understanding cancer signaling, The Scientist is bringing together a panel of experts to discuss their research and share insights into targeting these pathways with anti-cancer therapeutics. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.
Topics to be covered:
Lynne-Marie Postovit, PhD
Associate Professor, Department of Experimental Oncology
University of Alberta
William Weiss, MD, PhD
Professor, Departments of Neurology, Pediatrics, and Neurosurgery
University of California, San Francisco